Telomir Pharmaceuticals logo

Telomir Pharmaceuticals Share Price (NASDAQ: TELO)

$1.33

-0.15

(-10.14%)

Last updated on

Check the interactive Telomir Pharmaceuticals Stock chart to analyse performance

Telomir Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.30
    Today's High:$1.42

    Day's Volatility :8.45%

  • 52 Weeks Low:$1.12
    52 Weeks High:$8.40

    52 Weeks Volatility :86.67%

Telomir Pharmaceuticals Stock Returns

PeriodTelomir Pharmaceuticals Inc Index (Russel 2000)
3 Months
-36.9%
0.0%
6 Months
-67.76%
0.0%
1 Year
-73.29%
0.0%
3 Years
-73.5%
-4.7%

Telomir Pharmaceuticals Inc Key Stats

Check Telomir Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.48
Open
$1.41
Today's High
$1.42
Today's Low
$1.3
Market Capitalization
$47.8M
Today's Volume
$2.7M
52 Week High
$8.4
52 Week Low
$1.12
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1569.59%

Stock Returns calculator for Telomir Pharmaceuticals Stock including INR - Dollar returns

The Telomir Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Telomir Pharmaceuticals investment value today

Current value as on today

₹30,666

Returns

₹69,334

(-69.33%)

Returns from Telomir Pharmaceuticals Stock

₹74,618 (-74.62%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Telomir Pharmaceuticals Stock

-50%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Telomir Pharmaceuticals Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Telomir Pharmaceuticals Stock

Rating
Trend

Telomir Pharmaceuticals Share Price Target

What analysts predicted

Upside of 1065.41%

Target:

$15.50

Current:

$1.33

Telomir Pharmaceuticals share price target is $15.50, a slight Upside of 1065.41% compared to current price of $1.33 as per analysts' prediction.

Telomir Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, TELO stock has moved down by -8.6%
  • TELO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 144.6%

Telomir Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Telomir Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Telomir Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Telomir Pharmaceuticals Inc  logo
-24.72%
-67.76%
-73.29%
-73.5%
-73.5%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Organization
Telomir Pharmaceuticals
Employees
0
CEO
Mr. Erez Aminov
Industry
Miscellaneous

Key Management of Telomir Pharmaceuticals Inc

NameTitle
Mr. Erez Aminov
Chairman of the Board & CEO
Mr. Alan Weichselbaum CPA, M.B.A.
Chief Financial Officer
Dr. Itzchak Angel Ph.D.
Chief Scientific Advisor

Important FAQs about investing in TELO Stock from India :

What is Telomir Pharmaceuticals share price today?

Telomir Pharmaceuticals share price today is $1.33 as on at the close of the market. Telomir Pharmaceuticals share today touched a day high of $1.42 and a low of $1.30.

What is the 52 week high and 52 week low for Telomir Pharmaceuticals share?

Telomir Pharmaceuticals share touched a 52 week high of $8.40 and a 52 week low of $1.12. Telomir Pharmaceuticals stock price today i.e. is closed at $1.33, lower by 84.17% versus the 52 week high.

How to invest in Telomir Pharmaceuticals Stock (TELO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Telomir Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telomir Pharmaceuticals Shares that will get you 1.1278 shares as per Telomir Pharmaceuticals share price of $1.33 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Telomir Pharmaceuticals Stock (TELO) from India?

Indian investors can start investing in Telomir Pharmaceuticals (TELO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Telomir Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Telomir Pharmaceuticals share’s latest price of $1.33 as on August 30, 2025 at 1:29 am IST, you will get 7.5188 shares of Telomir Pharmaceuticals. Learn more about fractional shares .

What are the returns that Telomir Pharmaceuticals has given to Indian investors in the last 5 years?

Telomir Pharmaceuticals stock has given -73.5% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?